GLP-1 News: Latest Updates on Weight Loss and Diabetes Medications In This Article Understanding GLP-1 Medications and Current News Oral GLP-1s Are Now a Reality FDA Sends Warning Letters to Telehealth Companies Clinical Trial Results Show Expanding Benefits Healthy Habits Remain Essential Understanding Side Effects and Safety Supply and Access Updates Making Informed Decisions About GLP-1 Medications References Understanding GLP-1 Medications and Current News GLP-1 receptor agonists have become some of the most talked about medications in recent years
Contraindications to be aware of: GLP-1 medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
In Q1 2026, Eli Lilly's revenue grew 56% to 19.8 billion USD
PubMed Thomas, M.K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., et al